Forward Planning Analysis, Innovation, Patient Centricity and FDA Compliance as a Strategic Framework To Execute Successful REMS Programs

August 2-3, 2022 | Alexandria, VA

Speaker Faculty

Anupam Agarwal
Anupam Agarwal
Vice President, Global Head of Drug Safety and Pharmacovigilance

ZOGENIX

Eleni Samaras Allen
Eleni Samaras Allen
Director, REMS Strategy and Execution

GSK

Nancy Dubois
Nancy Dubois
Head of Global Patient Safety/US Region

EMD SERONO

Kal Elhoregy
Kal Elhoregy
Director, Risk Evaluation and Mitigation Strategy (REMS) Programs

AMNEAL PHARMACEUTICALS

Kishore Gopu
Kishore Gopu
Senior Director, REMS Operations

TEVA PHARMACEUTICALS

Suzanne Marinello
Suzanne Marinello
Risk Management Lead

JOHNSON & JOHNSON

Jaylaxmi Nalawade
Jaylaxmi Nalawade
Associate Director – Pharmacovigilance and REMS

LUPIN PHARMACEUTICALS

Catina O’Leary
Catina O’Leary
President and CEO

HEALTH LITERACY MEDIA

Matt Page
Matt Page
Team Lead, Center for Post Approval Safety Studies

TAKEDA

Michele Riggen
Michele Riggen
Associate Director, KAB Programs

UBC

Carmit Strauss
Carmit Strauss
Director, Global Safety (Benefit Risk Management Officer)

AMGEN

Bill Trombetta
Bill Trombetta
Professor of Healthcare Strategy & Marketing

SAINT JOSEPH’S UNIVERSITY

Sheline Way
Sheline Way
Associate Director, REMS Operations

TEVA PHARMACEUTICALS